Assessment of fibrinolytic status in whole blood using a dielectric coagulometry microsensor

ClotChip Portable Blood Clotting Sensor

“…13 Furthermore, the technology is described as requiring no special expertise or training to operate the device, making it usable by patients, caregivers, and clinicians alike. 7 The benefits of ClotChip for assessing and/or monitoring the blood's ability to clot may extend to patients in acute and/or trauma care settings, 5,14 and cardiac surgical settings, 15 as well as those with established clotting disorders. 12,13 In addition, patients who are receiving anticoagulant therapy -such as direct oral anticoagulants (DOACs) -may also benefit from the availability of a PoC device such as ClotChip (i.e., in acute care and emergency surgery settings), as a rapid and accurate assessment of the effects of DOAC therapy on the blood's ability to clot can support safe and effective treatment decisions.…”

“…Since then, additional work has been initiated to assess the utility of ClotChip for patients with traumatic injuries 14 as a presurgical screening tool, and for patients who may be at risk from COVID-19 clotting defects. 7 The ability to rapidly detect clotting abnormalities has become increasingly important in recent years due to COVID-related complications that affect coagulation.…”